Catalyst Wire Dossier Catalyst Wire Dossier

HP neoadjuvant therapy

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HP neoadjuvant therapy, covering 2023-07-14 to 2023-07-14. Get the full timeline:

Most recent: Clinical Trial Update: A Trial of Eribulin in Combination With HP Neoadjuvant Therapy in Patients With for HER2-Positive BC [Phase 2]

See pricing